urology
CROES PCNL Outcome Score
Predicts stone-free rate after percutaneous nephrolithotomy (PCNL) based on patient and stone characteristics.
Score interpretation
High stone-free rate expected (>80%)
→ Good PCNL candidate; single session likely sufficient
Moderate stone-free rate (50-80%)
→ PCNL appropriate; may require second session; discuss risks
Lower stone-free rate (<50%)
→ Complex case; staged PCNL; multidisciplinary planning; consider SWL combination
Interpretation bands for the PCNL Outcome. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Tafluprost 0.0015% Eye Drops · Prostaglandin Analogue — Glaucoma (Preservative-Free)
- Triamcinolone Acetonide (Intravitreal / Periocular) · Corticosteroid — Periocular or Intravitreal Injection
- Dorzolamide / Timolol Fixed Combination (Cosopt) · Fixed Combination Glaucoma Treatment — CAI + Beta-blocker
- Tafluprost · Prostaglandin F2α analogue (preservative-free)
- Tafluprost with timolol · Prostaglandin + β-blocker (preservative-free)
- Allopurinol · Xanthine Oxidase Inhibitor — Uric Acid Stone Prevention
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.